In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V-Reference-Cited by-同舟云学术

In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V

Published:2010-09 Issue:9 Volume:38 Page:744-755
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Böhm Alexandra,Sonneck Karoline,Gleixner Karoline V.,Schuch Karina,Pickl Winfried F.,Blatt Katharina,Peter Barbara,Herrmann Harald,Schernthaner Gerit-Holger,Pehamberger Hubert,Rabitsch Werner,Sperr Wolfgang R.,Valent Peter

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference48 articles.

1. Mastocytosis: current concepts in diagnosis and treatment;Escribano;Ann Hematol,2002

2. Diagnosis and treatment of systemic mastocytosis: state of the art;Valent;Br J Haematol,2003

3. Systemic mastocytosis;Akin;Annu Rev Med,2004

4. Mast cells and mastocytosis;Metcalfe;Blood,2008

5. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder;Nagata;Proc Natl Acad Sci U S A,1995

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic mastocytosis in adults: 2023 update on diagnosis, risk stratification and management;American Journal of Hematology;2023-05-22

2. Sodium butyrate supresses malignant human mast cell proliferation, downregulates expression of KIT and promotes differentiation;Frontiers in Allergy;2023-03-10

3. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User’s Guide for Daily Clinical Practice;The Journal of Allergy and Clinical Immunology: In Practice;2022-08

4. Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update;Cancers;2022-07-17

5. Superior Efficacy of Midostaurin Over Cladribine in Advanced Systemic Mastocytosis: A Registry-Based Analysis;Journal of Clinical Oncology;2022-06-01